The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
β-Thalassemia
Abstract
β-Thalassemia, which is caused by a decrease in the production of β-globin chains, affects multiple organs and is associated with considerable morbidity and mortality. Lifelong care is required, and the costs of proper treatment are substantial. This review discusses current approaches to the management of β-thalassemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
Ganz, T. (2003) · Blood · doi:10.1182/blood-2003-03-0672 · Cited by 1,544
Steinberg, M. H., Barton, F., Castro, O., Pegelow, C. H., Ballas, S. K., Kutlar, A., Orringer, E., Bellevue, R., Olivieri, N., Eckman, J., et al. (2003) · JAMA · doi:10.1001/jama.289.13.1645 · Cited by 931
Olivieri, N. F. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907083410207 · Cited by 728
Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias
Weatherall, D. J. (2001) · Nature Reviews Genetics · doi:10.1038/35066048 · Cited by 692
Survival in β-thalassaemia major in the UK: data from the UK Thalassaemia Register
Modell, B., Khan, M., & Darlison, M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02357-6 · Cited by 583
May, C., Rivella, S., Callegari, J., Heller, G., Gaensler, K. M. L., Luzzatto, L., & Sadelain, M. (2000) · Nature · doi:10.1038/35017565 · Cited by 567
The hypercoagulable state in thalassemia
Eldor, A., & Rachmilewitz, E. A. (2002) · Blood · doi:10.1182/blood.v99.1.36 · Cited by 503
Self-citationLabile plasma iron in iron overload: redox activity and susceptibility to chelation
Esposito, B. P., Breuer, W., Sirankapracha, P., Pootrakul, P., Hershko, C., & Cabantchik, Z. I. (2003) · Blood · doi:10.1182/blood-2003-03-0807 · Cited by 475
Complications of β-thalassemia major in North America
Cunningham, M. J., Macklin, E. A., Neufeld, E. J., Cohen, A. R., & the Thalassemia Clinical Research Network (2004) · Blood · doi:10.1182/blood-2003-09-3167 · Cited by 454
Hepcidin in iron overload disorders
Papanikolaou, G., Tzilianos, M., Christakis, J. I., Bogdanos, D., Tsimirika, K., MacFarlane, J., Goldberg, Y. P., Sakellaropoulos, N., Ganz, T., & Nemeth, E. (2005) · Blood · doi:10.1182/blood-2004-12-4844 · Cited by 445
Anderson, L. J., Wonke, B., Prescott, E., Holden, S., Malcolm Walker, J., & Pennell, D. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09740-4 · Cited by 430
Non‐Specific Serum Iron in Thalassaemia: an Abnormal Serum Iron Fraction of Potential Toxicity
Hershko, C., Graham, G., Bates, G. W., & Rachmilewitz, E. A. (1978) · British Journal of Haematology · doi:10.1111/j.1365-2141.1978.tb03662.x · Cited by 423
Self-citationRelated umbilical cord blood transplantation in patients with thalassemia and sickle cell disease
Locatelli, F. (2003) · Blood · doi:10.1182/blood-2002-07-2090 · Cited by 386
DNA sequence variation associated with elevated fetal G gamma globin production
Gilman, J., & Huisman, T. (1985) · Blood · doi:10.1182/blood.v66.4.783.783 · Cited by 373
Global Epidemiology of Hemoglobin Disorders
ANGASTINIOTIS, M., & MODELL, B. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10482.x · Cited by 350
Nisbet-Brown, E., Olivieri, N. F., Giardina, P. J., Grady, R. W., Neufeld, E. J., Séchaud, R., Krebs-Brown, A. J., Anderson, J. R., Alberti, D., Sizer, K. C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13309-0 · Cited by 328
Cappellini, M. D., Robbiolo, L., Bottasso, B. M., Coppola, R., Fiorelli, G., & Mannucci, A. P. M. (2000) · British Journal of Haematology · doi:10.1111/j.1365-2141.2000.02376.x · Cited by 297
Brittenham, G. M., Cohen, A. R., McLaren, C. E., Martin, M. B., Griffith, P. M., Nienhuis, A. W., Young, N. S., Allen, C. J., Farrell, D. E., & Harris, J. W. (1993) · American Journal of Hematology · doi:10.1002/ajh.2830420116 · Cited by 270
Apoptotic Role of Fas/Fas Ligand System in the Regulation of Erythropoiesis
De Maria, R., Testa, U., Luchetti, L., Zeuner, A., Stassi, G., Pelosi, E., Riccioni, R., Felli, N., Samoggia, P., & Peschle, C. (1999) · Blood · doi:10.1182/blood.v93.3.796 · Cited by 269
Iannone, R., Casella, J. F., Fuchs, E. J., Chen, A. R., Jones, R. J., Woolfrey, A., Amylon, M., Sullivan, K. M., Storb, R. F., & Walters, M. C. (2003) · Biology of Blood and Marrow Transplantation · doi:10.1016/s1083-8791(03)00192-7 · Cited by 269
Role of deferiprone in chelation therapy for transfusional iron overload
Hoffbrand, A. V., Cohen, A., & Hershko, C. (2003) · Blood · doi:10.1182/blood-2002-06-1867 · Cited by 244
Apoptotic mechanisms in the control of erythropoiesis
Testa, U. (2004) · Leukemia · doi:10.1038/sj.leu.2403383 · Cited by 228
Preimplantation genetic diagnosis
Braude, P., Pickering, S., Flinter, F., & Ogilvie, C. M. (2002) · Nature Reviews Genetics · doi:10.1038/nrg953 · Cited by 220
Marrow transplantation for patients with thalassemia: results in class 3 patients
Lucarelli, G., Clift, R., Galimberti, M., Polchi, P., Angelucci, E., Baronciani, D., Giardini, C., Andreani, M., Manna, M., Nesci, S., et al. (1996) · Blood · doi:10.1182/blood.v87.5.2082.2082 · Cited by 216
The safety and effectiveness of deferiprone in a large‐scale, 3‐year study in Italian patients
Ceci, A., Baiardi, P., Felisi, M., Cappellini, M. D., Carnelli, V., De Sanctis, V., Galanello, R., Maggio, A., Masera, G., Piga, A., et al. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03554.x · Cited by 215
Voskaridou, E., & Terpos, E. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05143.x · Cited by 208
Sodani, P., Gaziev, D., Polchi, P., Erer, B., Giardini, C., Angelucci, E., Baronciani, D., Andreani, M., Manna, M., Nesci, S., et al. (2004) · Blood · doi:10.1182/blood-2003-08-2800 · Cited by 201
Rivella, S., Callegari, J., May, C., Tan, C., & Sadelain, M. (2000) · Journal of Virology · doi:10.1128/.74.10.4679-4687.2000 · Cited by 201
Ding, C., Chiu, R. W. K., Lau, T. K., Leung, T. N., Chan, L. C., Chan, A. Y. Y., Charoenkwan, P., Ng, I. S. L., Law, H.-Y., Ma, E. S. K., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403962101 · Cited by 194
Andreani, M., Nesci, S., Lucarelli, G., Tonucci, P., Rapa, S., Angelucci, E., Persini, B., Agostinelli, F., Donati, M., & Manna, M. (2000) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702151 · Cited by 191
Adherence of phosphatidylserine-exposing erythrocytes to endothelial matrix thrombospondin
Manodori, A. B., Barabino, G. A., Lubin, B. H., & Kuypers, F. A. (2000) · Blood · doi:10.1182/blood.v95.4.1293.004k42_1293_1300 · Cited by 190
Successful correction of the human β-thalassemia major phenotype using a lentiviral vector
Puthenveetil, G., Scholes, J., Carbonell, D., Qureshi, N., Xia, P., Zeng, L., Li, S., Yu, Y., Hiti, A. L., Yee, J.-K., et al. (2004) · Blood · doi:10.1182/blood-2004-04-1427 · Cited by 182
Cohen, A. R., Galanello, R., Pennell, D. J., Cunningham, M. J., & Vichinsky, E. (2004) · Hematology · doi:10.1182/asheducation-2004.1.14 · Cited by 176
Wanless, I. R. (2002) · Blood · doi:10.1182/blood-2002-01-0306 · Cited by 175
Pootrakul, P., Sirankapracha, P., Hemsorach, S., Moungsub, W., Kumbunlue, R., Piangitjagum, A., Wasi, P., Ma, L., & Schrier, S. L. (2000) · Blood · doi:10.1182/blood.v96.7.2606 · Cited by 167
Lacerra, G., Sierakowska, H., Carestia, C., Fucharoen, S., Summerton, J., Weller, D., & Kole, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9591 · Cited by 159
Oxidative status and malondialdehyde in β‐thalassaemia patients
Cighetti, G., Duca, L., Bortone, L., Sala, S., Nava, I., Fiorelli, G., & Cappellini, M. D. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.0320s1055.x · Cited by 159
Loss of α-hemoglobin–stabilizing protein impairs erythropoiesis and exacerbates β-thalassemia
Kong, Y., Zhou, S., Kihm, A. J., Katein, A. M., Yu, X., Gell, D. A., Mackay, J. P., Adachi, K., Foster-Brown, L., Louden, C. S., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21982 · Cited by 158
Mathias, L. A., Fisher, T. C., Zeng, L., Meiselman, H. J., Weinberg, K. I., Hiti, A. L., & Malik, P. (2000) · Experimental Hematology · doi:10.1016/s0301-472x(00)00555-5 · Cited by 158
Centis, F., Tabellini, L., Lucarelli, G., Buffi, O., Tonucci, P., Persini, B., Annibali, M., Emiliani, R., Iliescu, A., Rapa, S., et al. (2000) · Blood · doi:10.1182/blood.v96.10.3624.h8003624_3624_3629 · Cited by 150
Voskaridou, E., Douskou, M., Terpos, E., Papassotiriou, I., Stamoulakatou, A., Ourailidis, A., Loutradi, A., & Loukopoulos, D. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05104.x · Cited by 148
Imren, S., Fabry, M. E., Westerman, K. A., Pawliuk, R., Tang, P., Rosten, P. M., Nagel, R. L., Leboulch, P., Eaves, C. J., & Humphries, R. K. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21838 · Cited by 144
Fucharoen, S., Siritanaratkul, N., Winichagoon, P., Chowthaworn, J., Siriboon, W., Muangsup, W., Chaicharoen, S., Poolsup, N., Chindavijak, B., Pootrakul, P., et al. (1996) · Blood · doi:10.1182/blood.v87.3.887.bloodjournal873887 · Cited by 143
Unrelated donor bone marrow transplantation for thalassemia: the effect of extended haplotypes
Nasa, G. L., Giardini, C., Argiolu, F., Locatelli, F., Arras, M., Stefano, P. D., Ledda, A., Pizzati, A., Sanna, M. A., Vacca, A., et al. (2002) · Blood · doi:10.1182/blood.v99.12.4350 · Cited by 143
Mourad, F. H., Hoffbrand, A. V., Sheikh‐Taha, M., Koussa, S., Khoriaty, A. I., & Taher, A. T. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04240.x · Cited by 140
Galanello, R., Piga, A. G., Alberti, D., Rouan, M. C., Bigler, H., & Séchaud, R. (2003) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003253350 · Cited by 140
Chelation therapy in [beta ]-thalassemia: An optimistic update
Giardina, P. J., & Grady, R. W. (2001) · Seminars in Hematology · doi:10.1016/s0037-1963(01)90030-7 · Cited by 129
Hanawa, H., Hargrove, P. W., Kepes, S., Srivastava, D. K., Nienhuis, A. W., & Persons, D. A. (2004) · Blood · doi:10.1182/blood-2004-03-0863 · Cited by 123
Moreau‐Gaudry, F., Xia, P., Jiang, G., Perelman, N., Bauer, G., Ellis, J., Surinya, K. H., Mavilio, F., Shen, C.-K. J., & Malik, P. (2001) · Blood · doi:10.1182/blood.v98.9.2664 · Cited by 123
Emery, D. W., Yannaki, E., Tubb, J., Nishino, T., Li, Q., & Stamatoyannopoulos, G. (2002) · Blood · doi:10.1182/blood-2002-01-0219 · Cited by 123
Advani, R. H., Sorenson, S., Shinar, E., Lande, W. M., Rachmilewitz, E. A., & Schrier, S. L. (1992) · Blood · doi:10.1182/blood.v79.4.1058.1058 · Cited by 117
Self-citationHydroxyurea can eliminate transfusion requirements in children with severe β-thalassemia
Bradai, M., Abad, M. T., Pissard, S., Lamraoui, F., Skopinski, L., & de Montalembert, M. (2003) · Blood · doi:10.1182/blood-2003-01-0117 · Cited by 116
Link, G., Konijn, A. M., Breuer, W. V., Cabantchik, Z. I., & Hershko, C. (2001) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2001.116487 · Cited by 110
Effects of N ‐acetylcysteine on dense cell formation in sickle cell disease
Pace, B. S., Shartava, A., Pack-Mabien, A. V., Mulekar, M., Ardia, A., & Goodman, S. R. (2003) · American Journal of Hematology · doi:10.1002/ajh.10321 · Cited by 103
Availability of unrelated donors for hematopoietic stem cell transplantation for hemoglobinopathies
Krishnamurti, L., Abel, S., Maiers, M. J., & Flesch, S. (2003) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703887 · Cited by 95
Shalev, O., Repka, T. L., Goldfarb, A. W., Grinberg, L. N., Abrahamov, A., Olivieri, N. F., Rachmilewitz, E. A., & Hebbel, R. (1995) · Blood · doi:10.1182/blood.v86.5.2008.bloodjournal8652008 · Cited by 94
Self-citationDiffering erythrocyte membrane skeletal protein defects in alpha and beta thalassemia.
Shinar, E., Rachmilewitz, E. A., & Lux, S. E. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113898 · Cited by 94
Self-citationRachmilewitz, E. A., Weizer‐Stern, O., Adamsky, K., Amariglio, N., Rechavi, G., Breda, L., Rivella, S., & Cabantchik, Z. I. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.014 · Cited by 93
Self-citationTesoriere, L., D’Arpa, D., Butera, D., Allegra, M., Renda, D., Maggio, A., Bongiorno, A., & Livrea, M. A. (2001) · Free Radical Research · doi:10.1080/10715760100300461 · Cited by 93
Lifetime treatment costs of β-thalassaemia major
Karnon, J. D., Zeuner, D., Brown, J., Ades, A. E., Wonke, B., & Modell, B. (1999) · Clinical & Laboratory Haematology · doi:10.1046/j.1365-2257.1999.00262.x · Cited by 88
Membrane‐bound iron contributes to oxidative damage of β‐thalassaemia intermedia erythrocytes
Tavazzi, D., Duca, L., Graziadei, G., Comino, A., Fiorelli, G., & Cappellini, M. D. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02482.x · Cited by 82
Pootrakul, P., Sirankapracha, P., Sankote, J., Kachintorn, U., Maungsub, W., Sriphen, K., Thakernpol, K., Atisuk, K., Fucharoen, S., Chantraluksri, U., et al. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04412.x · Cited by 78
Oxidative status of platelets in normal and thalassemic blood
Amer, J., & Fibach, E. (2004) · Thrombosis and Haemostasis · doi:10.1160/th04-04-0234 · Cited by 73
Pharmacological induction of fetal hemoglobin in sickle cell disease and [beta ]-thalassemia
Atweh, G. F., & Loukopoulos, D. (2001) · Seminars in Hematology · doi:10.1016/s0037-1963(01)90031-9 · Cited by 64
Leukoreduction of blood components
Dzik, S. (2002) · Current Opinion in Hematology · doi:10.1097/00062752-200211000-00010 · Cited by 62
Vacek, M. M., Ma, H., Gemignani, F., Lacerra, G., Kafri, T., & Kole, R. (2002) · Blood · doi:10.1182/blood-2002-06-1869 · Cited by 56
Rachmilewitz, E. A., Aker, M., Perry, D. J., & Dover, G. H. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb05156.x · Cited by 49
Self-citationPathophysiology of [alpha ]- and [beta ]-thalassemia: Therapeutic implications
Rund, D. G., & Rachmilewitz, E. A. (2001) · Seminars in Hematology · doi:10.1016/s0037-1963(01)90028-9 · Cited by 44
Self-citationIron-chelation therapy: an update
Franchini, M., & Veneri, D. (2004) · The Hematology Journal · doi:10.1038/sj.thj.6200407 · Cited by 42
Naro, E. D. (2000) · Molecular Human Reproduction · doi:10.1093/molehr/6.6.571 · Cited by 40
GROWTH AND ENDOCRINE FUNCTION FOLLOWING BONE MARROW TRANSPLANTATION FOR THALASSEMIA MAJOR
Li, C. K., Chik, K. W., Wong, G., Cheng, P. S., Lee, V., & Shing, M. M. K. (2004) · Pediatric Hematology and Oncology · doi:10.1080/08880010490457132 · Cited by 39
A signaling mechanism for growth-related expression of fetal hemoglobin
Bhanu, N. V., Trice, T. A., Lee, Y. T., & Miller, J. L. (2003) · Blood · doi:10.1182/blood-2003-05-1624 · Cited by 36
The Molecular Pathology of the Thalassaemias
Weatherall, D. J., & Clegg, J. B. (2001) · doi:10.1002/9780470696705.ch4 · Cited by 32
Umbilical Cord Blood Transplantation in Chinese Children With Beta-Thalassemia
Fang, J., Huang, S.-L., Chen, C., Zhou, D., Li, C. K., Li, Y., & Huang, K. (2004) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200403000-00008 · Cited by 26
Lung, H.-Y., Meeus, I. S., Weinberg, R. S., & Atweh, G. F. (2000) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2000.0343 · Cited by 24
Cell culture and animal models to screen for promising fetal hemoglobin-stimulating compounds
Fibach, E. (2001) · Seminars in Hematology · doi:10.1016/s0037-1963(01)90032-0 · Cited by 24
Zoueva, O. P., & Rodgers, G. P. (2004) · Experimental Hematology · doi:10.1016/j.exphem.2004.05.024 · Cited by 11
Diagnosis and management of thalassaemia
Welch, J. C. (2015) · Paediatrics and Child Health · doi:10.1016/j.paed.2015.03.001 · Cited by 9
Cited by
High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin
Tanno, T., Bhanu, N. V., Oneal, P. A., Goh, S.-H., Staker, P., Lee, Y. T., Moroney, J. W., Reed, C. H., Luban, N. L., Wang, R.-H., et al. (2007) · Nature Medicine · doi:10.1038/nm1629 · Cited by 854
Taher, A. T., Weatherall, D. J., & Cappellini, M. D. (2018) · The Lancet · doi:10.1016/s0140-6736(17)31822-6 · Cited by 807
Cao, A., & Galanello, R. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181cd68ed · Cited by 722
Exome sequencing and characterization of 49,960 individuals in the UK Biobank
Van Hout, C. V., Tachmazidou, I., Backman, J. D., Hoffman, J. D., Liu, D., Pandey, A. K., Gonzaga-Jauregui, C., Khalid, S., Ye, B., Banerjee, N., et al. (2020) · Nature · doi:10.1038/s41586-020-2853-0 · Cited by 561
Taher, A. T., Musallam, K. M., & Cappellini, M. D. (2021) · New England Journal of Medicine · doi:10.1056/nejmra2021838 · Cited by 477
Metadata
- Authors
- Rund, D., & Rachmilewitz, E.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-09-15
- Volume
- 353
- Issue
- 11
- Pages
- 1135-1146
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4246480901
- Cited by
- 939
- References
- 78
- FWCI
- 12.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.